The trajectory of companies tied to blockbuster drugs like Viagra presents a challenging investment landscape . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the loss of exclusivity in key territories has introduced substantial risk . Investors are now facing the consequences of gener